PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

CluePoints’ Technology Named as Finalist in 2025 Citeline Awards

RBQM and AI leader was shortlisted for its Time Similarity Test in the ‘Innovative Clinical Trial Solutions’ category

CluePoints, provider of leading statistical and AI-driven software solutions, has been named as a finalist in the ‘Innovative Clinical Trial Solutions’ category at the 2025 Citeline Awards.

CluePoints was shortlisted for its new statistical innovation included as part of CMP 3.0, the Time Similarity Test (TST). TST enhances the detection of unusual patterns in electronic patient-reported outcomes (ePRO) data. By analyzing audit trail timestamps, TST identifies when patients at a site enter data at unusually similar times, signaling potential fabrication or non-compliance. This enables sponsors to identify anomalies earlier and more easily, reducing timelines and costs while improving data quality and regulatory readiness.

Andy Cooper, CEO of CluePoints, commented: “It’s great to be shortlisted for another Citeline Award. The Citeline Awards are prestigious accolades, and we are honored to be acknowledged for our commitment to innovation alongside other industry leaders. Our new TST technology provides sponsors and CROs with the ability to interrogate ePRO audit trails to quickly identify concerning data entry patterns, thereby helping to avoid costly delays when preparing the clinical data for regulatory submission. This new test further enables our customers to run smarter clinical trials and bring new therapies to market faster, for the benefit of patients around the world.”

The winners of all categories of the 9th annual Citeline Awards will be announced at a ceremony on Thursday, May 8th at the Downtown Boston Theater District Hotel, Hyatt Regency Boston.

To learn more about CluePoints’ award-winning solutions, please visit www.cluepoints.com

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026